Double-blind

Double-blind is a term used in research design, particularly in psychology, medicine, and related fields. It refers to a type of study design where both the participants and the researchers are unaware of which participants receive the treatment or the placebo.

Definition

A double-blind study is a type of experimental design in which neither the participants nor the researchers know who is in the experimental group and who is in the control group until the results are analyzed. This is done to prevent bias in research results.

Purpose

The purpose of a double-blind study is to eliminate bias. By keeping both the researchers and the participants in the dark about who is receiving the actual treatment and who is receiving a placebo, the study can provide more accurate results.

Procedure

In a double-blind study, participants are randomly assigned to either the experimental group or the control group. The experimental group receives the treatment being studied, while the control group receives a placebo. Both the researchers and the participants do not know who is in which group until the study is over and the results are analyzed.

Advantages

Double-blind studies have several advantages. They can help to eliminate bias, as neither the researchers nor the participants know who is receiving the treatment. This can help to ensure that the results of the study are due to the treatment itself, and not due to expectations or perceptions. Double-blind studies can also help to increase the reliability and validity of research findings.

Disadvantages

Despite their advantages, double-blind studies also have some disadvantages. They can be more complex and costly to carry out than other types of research designs. In addition, there may be ethical considerations, as participants are not fully informed about the treatment they are receiving.

See also

• Single-blind study
• Placebo effect
• Randomized controlled trial

Double-blind Resources
Need Help Finding a Doctor? WikiMD's DocFinder can help find general and specialist physicians.	Latest articles Most recent articles Ongoing trials.